Glycyrrhizin-Induced Pseudohyperaldosteronism: A Case Report

Chin J Integr Med. 2022 Jul;28(7):644-649. doi: 10.1007/s11655-021-3312-y. Epub 2022 Jan 11.

Authors

Zong-Jing Fan^{1

2}, Jin-Min Liu¹, Xing-Xing Li², Jie Cui¹, Bin Guo¹, Quan Lin³, Rui Zhuang², Zheng-Bo Wu², Yang Wu⁴

Affiliations

¹ Department of Cardiology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, 100078, China.
² Department of Graduate School, Beijing University of Chinese Medicine, Beijing, 100029, China.
³ Department of Cardiology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, China.
⁴ Department of Cardiology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, 100078, China. 767584694@qq.com.

PMID: 35015223
DOI: 10.1007/s11655-021-3312-y

No abstract available

Publication types

Case Reports

MeSH terms

Glycyrrhizic Acid* / adverse effects
Humans
Hypertension*

Substances

Glycyrrhizic Acid